BREAKING
Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 3 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 3 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 1 hour ago Atmus Welcomes Heath Sharp to Board of Directors 57 minutes ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 1 hour ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago BrightView Q1 2026 Results: Revenue Beats Expectations but Profitability Challenges Weigh on Stock 2 days ago Fed Signals Potential Rate Cuts Amid Cooling Inflation Data 1 week ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 3 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 3 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 2 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 1 hour ago Atmus Welcomes Heath Sharp to Board of Directors 57 minutes ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 1 hour ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago BrightView Q1 2026 Results: Revenue Beats Expectations but Profitability Challenges Weigh on Stock 2 days ago Fed Signals Potential Rate Cuts Amid Cooling Inflation Data 1 week ago
ADVERTISEMENT

Moderna Inc (MRNA) Q4 2022 Earnings Call Transcript

Moderna Inc (NASDAQ:MRNA) Q4 2022 Earnings Call dated Feb. 23, 2023. Corporate Participants: Lavina Talukdar — Head of Investor Relations Stephane Bancel — Chief Executive Officer Stephen Hoge — President Arpa…

Moderna (MRNA) Earnings: 4Q22 Key Numbers

Moderna Inc. (NASDAQ: MRNA) reported total revenue of $5.1 billion for the fourth quarter of 2022, down 29% year-over-year due to a drop in COVID-19…

Moderna Inc (MRNA) Q3 2022 Earnings Call Transcript

Moderna Inc (NASDAQ:MRNA) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Lavina Talukdar — Head of Investor Relations Stephane Bancel — Chief Executive Officer Stephen Hoge — President Arpa…